Jetfuel T-300
Natural health product licensed in Canada
- Licence holder
- World Health Products LLC.
- NPN or DIN-HM
- 80052558
- Status
- Active licence
- Licence date
- 18 July 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Tribulus terrestris Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 133.32 mg Potency : 45 % Steroidal Saponins | 33.33 mg | Not calculated |
| Tribulus terrestris Source : Fruit | Not specified | Not calculated |
| Withania somnifera Source : Racine Extract : Matériel brut sec Extraction ratio : 8:1 Dry plant equivalent : 133.36 mg Potency : 2.5 % Withanolides | 16.67 mg | Not calculated |
| Withania somnifera Source : Racine | Not specified | Not calculated |
| Bore Source : Fructoborate de calcium | 0.233 mg | Not calculated |
| Zinc | 5 mg | 15,000 µg |
| Capsicum annuum Source : Fruit | 11.67 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, NA, Dioxyde de silicium, Dioxyde de titane, Glycolate d'amidon sodique, Phosphate dicalcique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Capsule ; maximum: 1 Capsule | maximum: 3 days |
Uses authorised in Canada
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Used (temporarily) as a mild diuretic. Helps the body to metabolize carbohydrates, fats and proteins. Helps to temporarily increase thermogenesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consult a health care practitioner if you are of childbearing age, pregnant or breastfeeding. Consumption with natural health products, ephedra, or other drugs which increase blood pressure is not recommended. Consult a health care practitioner prior to use if you are taking lithium. Consumption with other caffeine-containing products is not recommended. This product is not intended as a substitute for sleep. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Keep out of reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If you have stomach ulcers or inflammation, consult a health care practitioner prior to use.
- Effets indésirables connus
Caffeine may cause anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, nervousness, tremor and headache. Hypersensitivity/allergy is known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80052558
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.